synalar c
bioglan laboratories ltd - fluocinolone acetonide clioquinol - ointment - 0.025/3.0 %w/w
derma smoothe/fs liq 0.01% emulsion
hill dermaceuticals inc - fluocinolone acetonide - emulsion - 0.01% - fluocinolone acetonide 0.01% - anti-inflammatory agents
synalar solution
bausch health, canada inc. - fluocinolone acetonide - solution - 0.01% - fluocinolone acetonide 0.01% - anti-inflammatory agents
synalar ointment
bausch health, canada inc. - fluocinolone acetonide - ointment - 0.025% - fluocinolone acetonide 0.025% - anti-inflammatory agents
dermotic oil ear drops solution
hill dermaceuticals inc - fluocinolone acetonide - solution - 0.01% - fluocinolone acetonide 0.01% - corticosteroids
retisert implant
bausch & lomb inc - fluocinolone acetonide - implant - 0.59mg - fluocinolone acetonide 0.59mg - corticosteroids
otovel (- ciprofloxacin and fluocinolone acetonide solution
arbor pharmaceuticals - ciprofloxacin (unii: 5e8k9i0o4u) (ciprofloxacin - unii:5e8k9i0o4u), fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - ciprofloxacin 872.5 ug in 0.25 ml - otovel is indicated for the treatment of acute otitis media with tympanostomy tubes (aomt) in pediatric patients (aged 6 months and older) due to staphylococcus aureus, streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, and pseudomonas aeruginosa . otovel is contraindicated in: - patients with known hypersensitivity to fluocinolone acetonide or other corticosteroids, ciprofloxacin or other quinolones, or to any other components of otovel. - viral infections of the external ear canal, including varicella and herpes simplex infections and fungal otic infections. risk summary otovel is negligibly absorbed following otic administration and maternal use is not expected to result in fetal exposure to ciprofloxacin and fluocinolone acetonide [see clinical pharmacology (12.3) ]. risk summary otovel is negligibly absorbed by the mother following otic administration and breastfeeding is not expected to result in exposure of the infant to ciprofloxacin and fluocinolone acetonide [see clinical phar
iluvien implant
knight therapeutics inc. - fluocinolone acetonide - implant - 0.19mg - fluocinolone acetonide 0.19mg - corticosteroids
synalar- fluocinolone acetonide solution synalar ts- fluocinolone acetonide kit
medimetriks pharmaceuticals, inc. - fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - synalar® solution is indicated for the relief of the inflammatory and pruritic manifestations of corticosteriod-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
synalar- fluocinolone acetonide ointment
medimetriks pharmaceuticals, inc. - fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - synalar® ointment is indicated for the relief of the inflammatory and pruritic manifestations of corticosteriod-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.